Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

Atherosclerosis

Volumn 86, Issue 2-3, 1991, Pages 193-199

  Mackness, Michael I ^a   Harty, Derek ^a   Bhatnagar, Deepak ^a   Winocour, Peter H ^a   Arrol, Sharon ^a   Ishola, Monica ^a   Durrington, Paul N ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Familial hypercholesterolemia; Insulin dependent diabetes mellitus; Lipoproteins; Paraoxonase

Indexed keywords

ARYLESTERASE;

ARTICLE; DIABETES MELLITUS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

APOLIPOPROTEINS B; CHOLESTEROL; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA, FAMILIAL; LIPOPROTEINS, HDL CHOLESTEROL; MALE; MIDDLE AGE; PHOSPHORIC MONOESTER HYDROLASES; SUPPORT, NON-U.S. GOV'T; TRIGLYCERIDES;

EID: 0026099383     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(91)90215-O     Document Type: Article

References (32)

1. Serum esterases. 1. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination
2. Serum esterases. 2. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera
3. Distinction between ‘A’-esterases and arylesterases
4. ‘A’-esterase activity in the lipoprotein fraction of sheep serum
5. Genetic polymorphism and interethnic variability of plasma paraoxonase activity
6. The human serum paraoxonase polymorphism
7. Enzymatische Hydrolyse von Diaethyl p-nitrophenal phosphat (E600) durch menschliches Serum
8. Distribution of serum paraoxon hydrolysing activities in a Canadian population
9. Genetics of paraoxonase
10. Interethnic differences in paraoxonase activity. Relevance for the detoxification of organophosphorus compounds
11. The separation of sheep and human serum ‘A’-esterase activity into the lipoprotein fraction by ultracentrifugation
12. Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia
13. Low ‘A’-esterase activity in serum of patients with fish-eye disease
14. Absence of ‘A’-esterase activity in the serum of a patient with Tangier disease
15. Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction
16. Plasma high density lipoprotein concentration and the development of ischaemic heart disease
17. HDL cholesterol and other lipids in coronary heart disease
18. Apolipoprotein A-1 as a marker of angiographically assessed coronary artery disease
19. High density lipoproteins in myocardial infarction survivors
20. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol
21. Comparison of two commercial nephelometric methods for apoprotein AI and apoprotein B with standardised apoprotein AI and B radioimmunoassays
22. A comparison of methods for immunoassay of apolipoprotein B in man
23. Human serum organophosphatase: biochemical characteristics and polymorphic inheritance
24. Serum arylesterase (paraoxonase) activity following myocardial infarction
25. Serum esterase activities and hyperlipidaemia in the streptozotocin-diabetic rat
26. The low-density lipoprotein pathway and its relation to atherosclerosis
27. ‘A’-esterases. Enzymes looking for a role?
28. Beyond Cholesterol. Modifications of lowdensity lipoprotein that increase its atherogenicity
29. Lipoprotein oxidation and cytotoxicity Effect of probucol on streptozotocin-treated rats
30. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis
31. Could the human paraoxonase polymorphism account for different responses to certain environmental chemicals?